Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.

Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.

Item
http://www.wikidata.org/entity/Q38225794
EndothelinEpigenetic modulation as a therapeutic approach for pulmonary arterial hypertensionPharmacokinetic and pharmacodynamic evaluation of macitentan , a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials.Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2 O2 in resistance arteries from patients with cardiovascular disease.TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea.
P2860

Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.

Item
http://www.wikidata.org/entity/Q38225794
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current state of endothelin re ...... on and pulmonary hypertension.
@en
type
label
Current state of endothelin re ...... on and pulmonary hypertension.
@en
prefLabel
Current state of endothelin re ...... on and pulmonary hypertension.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Current state of endothelin re ...... on and pulmonary hypertension.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921